Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
Antonio Palumbo(University Hospital Brno), Bart Barlogie(University of Arkansas for Medical Sciences), Pieter Sonneveld(Erasmus MC Cancer Institute), Marie von Lilienfeld‐Toal(St James's University Hospital), Mario Boccadoro(University of Turin), Jesús F. San Miguel(Clinica Universidad de Navarra), Sagar Lonial(Emory University), Michel Attal(Université Fédérale de Toulouse Midi-Pyrénées), Brian G.M. Durie(Cedars-Sinai Medical Center), Stefan Knop(University of Tübingen), Heinz Ludwig(Wilhelminen Hospital), Joan Bladé(Hospital Clínic de Barcelona), Kenneth C. Anderson(Dana-Farber Cancer Institute), Meletios Α. Dimopoulos(Korea University), Jeffrey A. Zonder(The Barbara Ann Karmanos Cancer Institute), Robert Z. Orlowski(University of North Carolina at Chapel Hill), Paul G. Richardson(Harvard University), Orhan Sezer(Charité - Universitätsmedizin Berlin), Anders Waage(St Olav's University Hospital), S. Vincent Rajkumar(WinnMed), Sara Bringhen(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Michèle Cavo(Unknown), Andrew R. Belch, Rubén Niesvizky(Cornell University), Maurizio Zangari(University of Arkansas for Medical Sciences), Gareth J. Morgan(Hywel Dda University Health Board), Kazuyuki Shimizu(Spanish Head & Neck Cancer Cooperative Group), D. Joshua(Royal Prince Alfred Hospital), Jan Westin(Spanish Head & Neck Cancer Cooperative Group), M. A. Hussein(Cleveland Clinic), Jean‐Luc Harousseau(Institut de Cancérologie de l'Ouest), David H. Vesole(Hackensack University Medical Center), Diane Weber(The University of Texas MD Anderson Cancer Center), Robert A. Kyle(Mayo Clinic in Arizona)
Cited by 839
Related Papers
The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report
|The Lancet|2019|3k
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
|New England Journal of Medicine|2003|2.6k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k